-
4 Key Reasons The Mitalipov Paper Doesn't Herald Safe CRISPR Human Genetic Modification
The Niche | In Knoepfler lab's stem cell blog breaks down how the media's coverage of recent CRISPR news has been "too rosy and simplistic." The reality, Paul Knoepfler's team argues, is more complicated. There are overlooked technical reasons why the Mitalipov CRISPR human embryo paper is unlikely to herald safe human genetic modification.
Aug 8, 2017
-
DDN, Gatan Partner On Storage To Handle Microscopy Workflows
Bio-IT World News Brief DataDirect Networks has announced a strategic partnership with Gatan to deliver groundbreaking solutions for microscopy research environments and workflows. The DDN and Gatan partnership will combine DDN’s high-performance data storage platform with Gatan’s high-performance cameras to fully leverage the power of the latest technologies in electron microscopy.
Aug 7, 2017
-
Shkreli is convicted of fraud. Can pharma finally slam the door on him?
STAT | Martin Shrkeli, convicted of fraud on Friday, has been vilified as a price gouger by politicians, the public, and his fellow biopharma execs. What's next?
Aug 4, 2017
-
Veritas Buys Curoverse to Bring A.I. Analysis of Genes to the Masses
Xconomy | Some answers to questions about the risk of developing a disease or a bad reaction to a drug can be found by analyzing a patient's genes. In the not-too-distant future, such queries could be as easy as searching for and selecting a movie on Netflix, contends Rodrigo Martinez, chief marketing and design officer for Veritas Genetics.
Aug 3, 2017
-
Novogene Doubles Its Fleet Of PacBio Sequencers
Bio-IT World Brief | Yesterday Pacific Biosciences announced that Novogene had agreed to purchase 10 Sequel Systems, giving the DNA sequencing service provider the capacity to run up to 20 Sequel Systems at a time.
Aug 3, 2017
-
CRISPR Fixes Disease Gene In Viable Human Embryos
Bio-IT World Brief | An international team of researchers has used CRISPR–Cas9 gene editing to correct a disease-causing mutation in dozens of viable human embryos.
Aug 2, 2017
-
Edico Genome Announces Contracts With NHGRI, NCI
Bio-IT World Brief | Edico Genome today announced it has signed contracts with the National Human Genome Research Institute and the National Cancer Institute for the use of its DRAGEN Bio-IT platform.
Aug 2, 2017
-
Bright Computing Supports Fayetteville State University In AI Research
Bio-IT World Brief | Bright Computing announced it has supplied its Bright Cluster Manager solution to Fayetteville State University for use in ground-breaking Artificial Intelligence (AI) research.
Aug 2, 2017
-
Bioinformatics vs Computational Biology
Diamond Age Data Science | The world of quantitative biology is large, diffuse and sometimes overwhelming. It's hard sometimes to even figure out what someone means when they say "bioinformatics". This can make it hard to figure out what part of the field someone works in.
Aug 1, 2017
-
PerkinElmer, Thermo Scientific, Bioz, And More: News From July 2017
Bio-IT World Brief | July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including PerkinElmer, Thermo Scientific, Bioz, and more.
Jul 31, 2017
-
DataCamp Nabs $4M For Data Science Courses, Moves To NY
Xconomy | DataCamp, which recently raised $4 million from investors, is in the process of moving out of its Boston-area office and relocating to a recently opened headquarters in New York.
Jul 28, 2017
-
Mark Zuckerberg, Priscilla Chan Donate $10M to Advance Health Using Big Data
UC San Francisco | Atul Butte, who is helping to guide UCSF into a new era of computational science and medicine, has been named the Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF.
Jul 28, 2017
-
Takeda And Schrödinger Team Up For Drug Discovery
Asian Scientist Magazine | To leverage each other's strengths and accelerate the drug discovery process, Takeda Pharmaceutical Company Limited has teamed up with Schrödinger Incorporated. The multi-target research collaboration is directed at treating diseases that are aligned with Takeda's core therapeutic areas of interest.
Jul 27, 2017


